Increasing association between a neuropeptide Y promoter polymorphism and body mass index during the course of development

Pediatric Obesity

Volumn 7, Issue 6, 2012, Pages 453-460

  Hohmann, S ^a   Buchmann, A F ^a   Witt, S H ^a   Rietschel, M ^a   Jennen Steinmetz, C ^a   Schmidt, M H ^a   Esser, G ^b   Banaschewski, T ^a   Laucht, M ^a,b  

^a CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^b UNIVERSITY OF POTSDAM   (Germany)

Author keywords

Development; Neuropeptide Y; Rs16147; Weight regulation

Indexed keywords

NEUROPEPTIDE Y;

ADOLESCENT; ADULT; ADULTHOOD; ALLELE; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CENTRAL NERVOUS SYSTEM; CHILD; CHILD GROWTH; FAT MASS AND OBESITY ASSOCIATED GENE; FEMALE; GENE; GENE EXPRESSION; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOTE; HUMAN; HUMAN EXPERIMENT; INFANT; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROMOTER REGION; SCHOOL CHILD;

EID: 84872781404     PISSN: 20476302     EISSN: 20476310     Source Type: Journal    
DOI: 10.1111/j.2047-6310.2012.00069.x     Document Type: Article

References (34)

1. Kurth BM, Schaffrath RA. The prevalence of overweight and obese children and adolescents living in Germany. Results of the German Health Interview and Examination Survey for Children and Adolescents (KiGGS). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2007; 50: 736-743.
2. Minth CD, Bloom SR, Polak JM, Dixon JE. Cloning, characterization, and DNA sequence of a human cDNA encoding neuropeptide tyrosine. Proc Natl Acad Sci USA 1984; 81: 4577-4581.
3. Takeuchi T, Gumucio DL, Yamada T, et al. Genes encoding pancreatic polypeptide and neuropeptide Y are on human chromosomes 17 and 7. J Clin Invest 1986; 77: 1038-1041.
4. Morton GJ, Cummings DE, Baskin DG, Barsh GS, Schwartz MW. Central nervous system control of food intake and body weight. Nature 2006; 443: 289-295.
5. Stanley BG, Kyrkouli SE, Lampert S, Leibowitz SF. Neuropeptide Y chronically injected into the hypothalamus: a powerful neurochemical inducer of hyperphagia and obesity. Peptides 1986; 7: 1189-1192.
6. Benoit SC, Clegg DJ, Woods SC, Seeley RJ. The role of previous exposure in the appetitive and consummatory effects of orexigenic neuropeptides. Peptides 2005; 26: 751-757.
7. Ammar AA, Sederholm F, Saito TR, et al. NPY-leptin: opposing effects on appetitive and consummatory ingestive behavior and sexual behavior. Am J Physiol Regul Integr Comp Physiol 2000; 278: R1627-R1633.
8. Marin Bivens CL, Thomas WJ, Stanley BG. Similar feeding patterns are induced by perifornical neuropeptide Y injection and by food deprivation. Brain Res 1998; 782: 271-280.
9. Kuo LE, Kitlinska JB, Tilan JU, et al. Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome. Nat Med 2007; 13: 803-811.
10. Baker E, Hort YJ, Ball H, et al. Assignment of the human neuropeptide Y gene to chromosome 7p15.1 by nonisotopic in situ hybridization. Genomics 1995; 26: 163-164.
11. Buckland PR, Hoogendoorn B, Guy CA, et al. A high proportion of polymorphisms in the promoters of brain expressed genes influences transcriptional activity. Biochim Biophys Acta 2004; 1690: 238-249.
12. Itokawa M, Arai M, Kato S, et al. Association between a novel polymorphism in the promoter region of the neuropeptide Y gene and schizophrenia in humans. Neurosci Lett 2003; 347: 202-204.
13. Zhou Z, Zhu G, Hariri AR, et al. Genetic variation in human NPY expression affects stress response and emotion. Nature 2008; 452: 997-1001.
14. Sommer WH, Lidstrom J, Sun H, et al. Human NPY promoter variation rs16147:T > C as a moderator of prefrontal NPY gene expression and negative affect. Hum Mutat 2010; 31: E1594-E1608.
15. Shah SH, Freedman NJ, Zhang L, et al. Neuropeptide Y gene polymorphisms confer risk of early-onset atherosclerosis. PLoS Genet 2009; 5: e1000318.
16. Lindell SG, Schwandt ML, Sun H, et al. Functional NPY variation as a factor in stress resilience and alcohol consumption in rhesus macaques. Arch Gen Psychiatry 2010; 67: 423-431.
17. Gilpin NW, Misra K, Herman MA, et al. Neuropeptide Y opposes alcohol effects on gamma-aminobutyric acid release in amygdala and blocks the transition to alcohol dependence. Biol Psychiatry 2011; 69: 1091-1099.
18. Yeung EH, Zhang C, Chen J, et al. Polymorphisms in the neuropeptide Y gene and the risk of obesity: findings from two prospective cohorts. J Clin Endocrinol Metab 2011; 96: E2055-E2062.
19. Lenroot RK, Giedd JN. Annual research review: developmental considerations of gene by environment interactions. J Child Psychol Psychiatry 2011; 52: 429-441.
20. Bergen SE, Gardner CO, Kendler KS. Age-related changes in heritability of behavioral phenotypes over adolescence and young adulthood: a meta-analysis. Twin Res Hum Genet 2007; 10: 423-433.
21. Lenroot RK, Schmitt JE, Ordaz SJ, et al. Differences in genetic and environmental influences on the human cerebral cortex associated with development during childhood and adolescence. Hum Brain Mapp 2009; 30: 163-174.
22. Pietilainen KH, Kaprio J, Rissanen A, et al. Distribution and heritability of BMI in Finnish adolescents aged 16y and 17y: a study of 4884 twins and 2509 singletons. Int J Obes Relat Metab Disord 1999; 23: 107-115.
23. Haworth CM, Carnell S, Meaburn EL, et al. Increasing heritability of BMI and stronger associations with the FTO gene over childhood. Obesity (Silver Spring) 2008; 16: 2663-2668.
24. Hakanen M, Raitakari OT, Lehtimaki T, et al. FTO genotype is associated with body mass index after the age of seven years but not with energy intake or leisure-time physical activity. J Clin Endocrinol Metab 2009; 94: 1281-1287.
25. Labayen I, Ruiz JR, Ortega FB, et al. Association between the FTO rs9939609 polymorphism and leptin in European adolescents: a possible link with energy balance control. The HELENA study. Int J Obes (Lond) 2011; 35: 66-71.
26. Laucht M, Esser G, Schmidt MH. Developmental outcome of infants born with biological and psychosocial risks. J Child Psychol Psychiatry 1997; 38: 843-853.
27. Laucht M, Esser G, Baving L, et al. Behavioral sequelae of perinatal insults and early family adversity at 8 years of age. J Am Acad Child Adolesc Psychiatry 2000; 39: 1229-1237.
28. Luppino FS, de Wit LM, Bouvy PF, et al. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry 2010; 67: 220-229.
29. Yeomans MR, Caton S, Hetherington MM. Alcohol and food intake. Curr Opin Clin Nutr Metab Care 2003; 6: 639-644.
30. Achenbach TM. Manual for the Child Behavior Checklist/4-18 and 1991 Profile. University of Vermont, Department of Psychiatry: Burlington, VT, 1991.
31. Achenbach T. Young Adult Self Report. University of Vermont, Department of Psychiatry: Burlington, VT, 1991.
32. Müller R, Abbet JP. Veränderungen im Konsum legaler und illegaler Drogen bei 11-16-jährigen Schülern unter Schirmherrschaft der Weltgesundheitsorganisation (WHO Europe). Schweizer Fachstelle für Alkoholprobleme: Lausanne, 1991.
33. Luquet S, Perez FA, Hnasko TS, Palmiter RD. NPY/ AgRP neurons are essential for feeding in adult mice but can be ablated in neonates. Science 2005; 310: 683-685.
34. Witt SH, Buchmann AF, Blomeyer D, et al. An interaction between a neuropeptide Y gene polymorphism and early adversity modulates endocrine stress responses. Psychoneuroendocrinology 2011; 36: 1010-1020.